| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-05 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |